by Reavis Daniel Moore | May 1, 2024
A cross-sectional nationwide survey of adults in the USA in 2021. Records captures the rate of psychedelic use, comorbid conditions, mental and physical health, and factors predictive of psychedelic use were assessed.
by Reavis Daniel Moore | May 1, 2024
Dataset from a double-blind controlled study. Studying the effects of four repeated doses of LSD titrate (13 or 26 μg) or placebo, administered to healthy adults at 3–4 day intervals, on mood, cognitive performance and responses to emotional tasks. Assesment was done...
by Reavis Daniel Moore | May 1, 2024
Online survey about the impact of the coronavirus pandemic on mental health in the U.S.
by Reavis Daniel Moore | May 1, 2024
Ketamine’s clinic manged mobile health application. This data set entails patients’ journals and submission of their periodic PHQ-9 (depression scale) and GAD-7 (anxiety scale) assessment questionnaire.
by Reavis Daniel Moore | May 1, 2024
Combined records and notes of psychedelic-assisted therapy protocol for oncology patients within palliative care center.
Recent Comments